“This report finally debunks the myth that drug makers have somehow been compelled to raise prices because of the discounts and rebates health plans and PBMs demand to reduce overall costs,” Mark Merritt, president and chief executive of the Pharmaceutical Care Management Association, said in a statement.
Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2024 PCMA. All Rights Reserved.